Biologically-Active Medical Devices Manufactured from Blood Plasma

Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.


9/3/14   First Clinical Use of Carmell Therapeutics’ Plasma-Based Biomaterial Reduces Infections, Speeds Healing of Bone Fractures   South African Orthopaedic Association Congress, Cape Town – Data presented this week from a recently completed clinical trial with the REPAIR™ Bon[...]
8/22/14   Natural Infection Reduction: first reported use of a novel blood plasma-based product for treating open tibia fractures   August 21, 2014 – Military Health System Research Symposium (MHSRS), Fort Lauderdale, FL – Dr. Jason Smith, Director of Research and Development a[...]
5/19/14   Carmell Therapeutics Receives NIH Phase I Grant to develop antimicrobial-eluting bioresorbable bone filler.   May 19, 2014 – PITTSBURGH -- Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accel[...]
4/1/14   Carmell Innovation Showcase Winner at ACA 2014 Summit   With the largest gathering of angel investors from around the world present, the Angel Capital Association's (ACA) 2014 Summit featured presentations [...]